John, ML; Hitzler, W; Scharrer, I
The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpuraANNALS OF HEMATOLOGY. Bd. 91. H. 4. 2012 S. 507-510
Horka, H; Staudt, V; Klein, M et al.
The Tick Salivary Protein Sialostatin L Inhibits the Th9-Derived Production of the Asthma-Promoting Cytokine IL-9 and Is Effective in the Prevention of Experimental AsthmaJOURNAL OF IMMUNOLOGY. Bd. 188. H. 6. 2012 S. 2669-2676
Reuter, S; Dehzad, N; Martin, H et al.
TLR3 but Not TLR7/8 Ligand Induces Allergic Sensitization to Inhaled AllergenJOURNAL OF IMMUNOLOGY. Bd. 188. H. 10. 2012 S. 5123-5131
Korn, S; Taube, C; Buhl, R
Treatment strategies for asthmaINTERNIST. Bd. 53. H. 4. 2012 S. 429-438
Kleemann, P; Distler, E; Wagner, EM et al.
Varicella-zoster virus glycoproteins B and E are major targets of CD4(+) and CD8(+) T cells reconstituting during zoster after allogeneic transplantationHAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 97. H. 6. 2012 S. 874-882
Konantz, Martina; Balci, Tugce B.; Hartwig, Udo F. et al.
Zebrafish xenografts as a tool for in vivo studies on human cancerAnnals of the New York Academy of Sciences. Bd. 1266. 2012 S. 124-137
Siebels, M; Rohrmann, K; Oberneder, R et al.
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX(A (R))) and interferon-alpha-2a in metastatic renal cell carcinoma patientsWORLD JOURNAL OF UROLOGY. Bd. 29. H. 1. 2011 S. 121-126
Attig, Sebastian; Price, Leah; Janetzki, Sylvia et al.
A critical assessment for the value of markers to gate-out undesired events in hla-peptide multimer staining protocolsJournal of translational medicine. Bd. 9. London: Biomed Central 2011 S. 108
Schmittel, A; Sebastian, M; von Weikersthal, LF et al.
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancerANNALS OF ONCOLOGY. Bd. 22. H. 8. 2011 S. 1798-1804
Hoos, A; Britten, CM; Huber, C et al.
A methodological framework to enhance the clinical success of cancer immunotherapyNATURE BIOTECHNOLOGY. Bd. 29. H. 10. 2011 S. 867-870